Targeting epidermal growth factor‐overexpressing triple‐negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor

OBJECTIVES: Traditional cancer therapy and regular immunotherapy are ineffective for treating triple‐negative breast cancer (TNBC) patients. Recently, chimeric antigen receptor‐engineered natural killer cells (CAR NK) have been applied to target several hormone receptors on different cancer cells to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Prolif
Main Authors: Liu, Yan, Zhou, Yehui, Huang, Kuo‐Hsiang, Fang, Xujie, Li, Ying, Wang, Feifei, An, Li, Chen, Qingfei, Zhang, Yunchao, Shi, Aihua, Yu, Shuang, Zhang, Jingzhong
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7445407/
https://ncbi.nlm.nih.gov/pubmed/32592435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12858
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados